Stocks making the biggest moves midday: Merck, Bristol-Myers Squibb, Align Technology and more

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

España Noticias Noticias

España Últimas Noticias,España Titulares

These are the stocks posting the largest moves in midday trading.

Check out the companies making headlines in midday trading. Bunge — Shares of the global crop trader and processor popped 5.2% after the company lifted its 2023 outlook and reported better-than-expected profit for the third quarter. Bunge's earnings were lower year-on-year, however. Comcast — Comcast shares fell 6.3% after the telecom giant reported a loss in high-speed broadband subscribers. Advertising revenue from NBCUniversal was also weak.

Align Technology — The medical device maker dropped 25% on Thursday after missing Wall Street forecasts in the third quarter and offering weak guidance for current-quarter revenue. Align posted $2.14 in earnings per share excluding items and $960 million in revenue in the third quarter. Analysts polled by LSEG expected earnings of $2.26 per share and revenue at $995 million. American Tower Corporation — The American real estate investment trust added 8.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 12. in ES
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Bristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Fuente: MarketWatch - 🏆 3. / 97 Leer más »

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
Fuente: CNBC - 🏆 12. / 72 Leer más »

Japanese stocks rise for second session as Hong Kong stocks gainSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
Fuente: MarketWatch - 🏆 3. / 97 Leer más »